PMV Pharmaceuticals, Inc. (PMVP) vs Seer, Inc. (SEER)

PMV Pharmaceuticals, Inc. and Seer, Inc. are both Biotechnology companies. PMV Pharmaceuticals, Inc. and Seer, Inc. are of similar size ($103.6M and $100.8M). PMV Pharmaceuticals, Inc. has the higher net margin (0.00% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 14 metrics below, Seer, Inc. leads on 8 and PMV Pharmaceuticals, Inc. on 6.

Valuation

Metric PMVP SEER Biotechnology median
P/E n/m n/m 7.88
P/S n/m 7.37 11.47
P/B 0.99 0.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.10 0.75 0.74
EV/Sales n/m (3.38) 10.73
Earnings yield (106.77%) (64.21%) (28.84%)
Free cash flow yield (100.36%) (41.96%) (23.03%)

Profitability

Metric PMVP SEER Biotechnology median
Gross margin 0.00% 47.70% 65.16%
Operating margin 0.00% (498.19%) 0.00%
Net margin 0.00% (478.05%) 0.00%
Free cash flow margin 0.00% (309.34%) 0.00%
Return on equity (70.93%) (26.45%) (57.72%)
Return on assets (64.04%) (23.47%) (49.22%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric PMVP SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 5.64%
EPS growth (last fiscal year) (29.82%) 7.91% —
Revenue growth, 5-year CAGR — 90.78% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMVP SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.70 14.74 4.73
Net debt to EBITDA 1.27 2.63 0.96

Dividend

Metric PMVP SEER Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PMVP SEER Biotechnology median
Market cap 100.81m 103.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack